Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/04/1995 | EP0674640A1 2-(2-substituted pyrrolidin-4-yl)thio-carbapenem derivatives |
10/04/1995 | EP0674634A1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
10/04/1995 | EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors |
10/04/1995 | EP0674516A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
10/04/1995 | EP0493608B1 Quinolonecarboxylic acid derivative |
10/04/1995 | EP0465581B1 Erythromycin derivatives |
10/04/1995 | CN1109507A Preparation for high efficiency anti-tumor gama-type interferon mutant and use |
10/03/1995 | US5455335 Glycosylated steroids |
10/03/1995 | US5455266 Enhanced chemotherapeutic compositions against microbial infections in fish, the preparation and use thereof |
10/03/1995 | US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase |
10/03/1995 | US5455251 Michellamine antiviral agents, compositions, and treatment methods |
10/03/1995 | US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
10/03/1995 | US5455238 Cephalosporins |
10/03/1995 | US5455232 Pharmaceutical preparation based on rhamnolipid |
10/03/1995 | CA1337182C Compounds related to antibiotic tan-749 and their production |
10/03/1995 | CA1337176C Pharmaceutical compositions for the inhibition of tumor metastasis |
10/01/1995 | CA2144499A1 Mono- and bicyclic dna gyrase inhibitors |
09/28/1995 | WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
09/28/1995 | WO1995025806A2 Packaging-deficient lentiviruses |
09/28/1995 | WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
09/28/1995 | WO1995025742A1 Pasteurellaceae antigens and related vaccines |
09/28/1995 | WO1995025741A1 Gnrh antagonists |
09/28/1995 | WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
09/28/1995 | WO1995025723A1 Anilide derivatives as fungicides |
09/28/1995 | WO1995025718A1 Vitamin-d amide derivatives |
09/28/1995 | WO1995025544A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
09/28/1995 | WO1995025539A1 Novel remedy for respiratory-tract viral disease |
09/28/1995 | WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY |
09/28/1995 | WO1995025525A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
09/28/1995 | WO1995023806A3 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
09/28/1995 | CA2186121A1 Pasteurellaceae antigens and related vaccines |
09/28/1995 | CA2186111A1 Novel remedy for respiratory-tract viral disease |
09/28/1995 | CA2186045A1 Gel for treatment of skin diseases and for disinfection of the skin |
09/28/1995 | CA2185813A1 Vitamin-d amide derivatives |
09/28/1995 | CA2185710A1 Gnrh antagonists |
09/27/1995 | EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications |
09/27/1995 | EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use |
09/27/1995 | EP0673426A1 Platelet-activating factor acetylhydrolase |
09/27/1995 | EP0673420A1 Mammalian receptors for interleukin-10 (il-10) |
09/27/1995 | EP0673370A1 Tropone-substituted phenyloxazolidinone antibacterial agents |
09/27/1995 | EP0673199A1 Stabilized lanthionine bacteriocin compositions |
09/27/1995 | EP0521103B1 Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
09/27/1995 | EP0440734B1 Diet composition to improve survival of patients during sepsis |
09/27/1995 | CN1108935A Agent of composition containing quanoxaline and riboside |
09/27/1995 | CN1108931A Rapamycin formulations for oral administration |
09/27/1995 | CN1108930A Soft gelatin capsule manufacture |
09/26/1995 | US5453533 Enzyme inhibitor |
09/26/1995 | US5453488 Amino-substituted heterocycles as renin inhibitors |
09/26/1995 | US5453433 Viricides; antiseptics to decontaminate polio, rhino and coxsackie viruses |
09/26/1995 | US5453273 M. canis containing ringworm vaccine |
09/26/1995 | CA1337117C Use of vanilloids for the treatment of herpes simplex infections |
09/26/1995 | CA1337116C Vaccine for protection of cats against feline infectious peritonitis |
09/21/1995 | WO1995025170A1 NOVEL MUTEINS OF IFN-$g(b) |
09/21/1995 | WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
09/21/1995 | WO1995025124A1 Methods to diagnose and treat hiv-1 infection |
09/21/1995 | WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
09/21/1995 | WO1995025108A1 Carbapenem compounds, compositions and methods of treatment |
09/21/1995 | WO1995025107A1 Triazole compounds and processes for the preparation thereof |
09/21/1995 | WO1995025106A1 Oxazolidinone derivatives and pharmaceutical compositions containing them |
09/21/1995 | WO1995024926A1 Formulation for use in inducing cytotoxic t-cells |
09/21/1995 | WO1995024925A1 Cytotoxic t-cell epitopes |
09/21/1995 | WO1995024924A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING α-GALACTOSYL EPITOPES |
09/21/1995 | WO1995024923A2 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
09/21/1995 | WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
09/21/1995 | WO1995024905A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments |
09/21/1995 | WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
09/21/1995 | DE4410637C1 Injizierbare Lösungen von Dirithromycin Injectable solutions of dirithromycin |
09/21/1995 | CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
09/21/1995 | CA2185651A1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
09/21/1995 | CA2185540A1 Formulation for use in inducing cytotoxic t-cells |
09/21/1995 | CA2185458A1 Carbapenem compounds, compositions and methods of treatment |
09/21/1995 | CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
09/21/1995 | CA2185129A1 Methods to diagnose and treat hiv-1 infection |
09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
09/20/1995 | EP0672670A1 Process for the preparation of clavulanic acid |
09/20/1995 | EP0672669A1 Process for the preparation of clavulanic acid |
09/20/1995 | EP0672411A1 Use of 2-methylamino-2-phenylcyclohexanon for the treatment of infections and as immunomodulator |
09/20/1995 | EP0672193A1 Oligonucleotides having a conserved g 4? core sequence |
09/20/1995 | EP0672192A1 Method for inhibition of viral morphogenesis |
09/20/1995 | EP0672153A1 Vector to deliver and express foreign gene |
09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
09/20/1995 | EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
09/20/1995 | EP0672144A1 Interleukin-6 receptor antagonists |
09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
09/20/1995 | EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
09/20/1995 | EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
09/20/1995 | EP0672123A1 Multifunctional surface protein of streptococci |
09/20/1995 | EP0672116A1 Deletion mutants as vaccines for cholera |
09/20/1995 | EP0672035A1 Pyrimidineamine derivatives and processes for the preparation thereof |
09/20/1995 | EP0672031A1 Catechol diethers as selective pde iv? inhibitors |
09/20/1995 | EP0671952A1 Method for nonspecific cellular immune stimulation |
09/20/1995 | EP0671951A1 Humanized antibodies reactive with l-selectin |
09/20/1995 | EP0671947A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
09/20/1995 | EP0671946A1 Immunoreactive peptides from epstein-barr virus |
09/20/1995 | EP0671943A1 Use of enzymes, especially bromelain, in the treatment of diarrhoea |
09/20/1995 | EP0671938A1 Novel biologically active peptides and uses therefor |
09/20/1995 | EP0671935A1 Amino acid conjugates of cyclohexapeptidyl amines |
09/20/1995 | EP0671930A1 Prophylaxis and treatment of adverse oral conditions with biologically active peptides |